Ad is loading...
LVORX
Price
$19.69
Change
-$0.24 (-1.20%)
Updated
Nov 15 closing price
VIMAX
Price
$337.33
Change
-$1.88 (-0.55%)
Updated
Nov 15 closing price
Ad is loading...

LVORX vs VIMAX

Header iconLVORX vs VIMAX Comparison
Open Charts LVORX vs VIMAXBanner chart's image
Lord Abbett Value Opportunities R3
Price$19.69
Change-$0.24 (-1.20%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$337.33
Change-$1.88 (-0.55%)
VolumeN/A
CapitalizationN/A
LVORX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LVORX vs. VIMAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVORX is a Buy and VIMAX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 175B vs. LVORX (1.4B). VIMAX pays higher dividends than LVORX: VIMAX (1.49) vs LVORX (0.00). LVORX was incepted earlier than VIMAX: LVORX (17 years) vs VIMAX (23 years). LVORX is a more actively managed with annual turnover of: 19.00 vs. VIMAX (13.00). LVORX has a lower initial minimum investment than VIMAX: LVORX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 28.29 vs. LVORX (26.46). VIMAX return over 5 years is better than : 59.04 vs. LVORX (6.78).
LVORXVIMAXLVORX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD17.41217.342100%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B175B1%
Annual Yield % from dividends0.001.49-
Returns for 1 year26.4628.2994%
Returns for 3 years-17.095.04-339%
Returns for 5 years6.7859.0411%
Returns for 10 years-8.96128.01-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RJF160.680.53
+0.33%
Raymond James Financial
INVZ0.49-0.01
-2.60%
Innoviz Technologies Ltd
BLKB81.00-3.00
-3.57%
Blackbaud
ZYME15.39-0.87
-5.35%
Zymeworks
AKTX2.08-0.15
-6.73%
Akari Therapeutics plc